Abstract

Imaging-guided percutaneous microwave ablation (MWA) with high thermal efficiency comprises rapid, successful management of small renal cell carcinomas (RCCs) in selected patients. Ultrasound Committee of Chinese Medical Association, Interventional Oncology Committee of Chinese Research Hospital Association developed evidence-based guidelines for MWA of RCCs after systematically reviewing the 1969–2019 literature. Systematic reviews, meta-analyses, randomized controlled trials, cohort, and case–control studies reporting MWA of RCCs were included and levels of evidence assessed. Altogether, 146 articles were identified, of which 35 reported percutaneous MWA for T1a RCCs and 5 articles for T1b RCCs. Guidelines were established based on indications, techniques, safety, and effectiveness of MWA for RCCs, with the goal of standardizing imaging-guided percutaneous MWA treatment of RCCs.

• Key points

• Microwave ablation is recommended for managing small renal cell carcinoma in selected patients.

• Imaging protocols are tailored based on the procedural plan, guidance, and evaluation.

• Patient’s selection evaluation, updated technique information, clinical efficacy, and complications are recommended to standardize management.

• A joint task force (multidisciplinary team) summarized the key elements of the standardized report.